David MD - Amgen Ex RD
| AMG Stock | EUR 277.10 0.45 0.16% |
Insider
David MD is Ex RD of Amgen Inc
| Age | 60 |
| Phone | 805 447 1000 |
| Web | https://www.amgen.com |
Amgen Management Efficiency
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Thomas Gorman | SIMS METAL MGT | N/A | |
| Brad Baker | SIMS METAL MGT | N/A | |
| Hiroyuki Kato | SIMS METAL MGT | 62 | |
| Ingrid Sinclair | SIMS METAL MGT | N/A | |
| William Schmiedel | SIMS METAL MGT | N/A | |
| Tracy Colden | Playa Hotels Resorts | 62 | |
| Gretchen Johanns | SIMS METAL MGT | N/A | |
| Stephen Skurnac | SIMS METAL MGT | N/A | |
| Geoffrey Brunsdon | SIMS METAL MGT | 60 | |
| Angela Catt | SIMS METAL MGT | N/A | |
| Deborah OToole | SIMS METAL MGT | 61 | |
| James Thompson | SIMS METAL MGT | 68 | |
| Dean Sullivan | Playa Hotels Resorts | N/A | |
| Heather Ridout | SIMS METAL MGT | 64 | |
| Gregory Maliassas | Playa Hotels Resorts | 50 | |
| Achileas Constantakopoulos | AEGEAN AIRLINES | N/A | |
| Michael Movsas | SIMS METAL MGT | N/A | |
| Dayna Blank | Playa Hotels Resorts | N/A | |
| CFA CFA | Playa Hotels Resorts | N/A | |
| Konstantinos Kalamatas | AEGEAN AIRLINES | N/A | |
| Georgia Nelson | SIMS METAL MGT | 68 | |
Management Performance
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 |
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Linda Louie, VP Officer | ||
| Robert Bradway, CEO Chairman | ||
| Peter Griffith, Ex CFO | ||
| Murdo Gordon, Ex Operations | ||
| Dagmar Bottenbruch, Independent Member of the Supervisory Board | ||
| Donatella Ceccarelli, Independent Member of the Supervisory Board | ||
| Nancy Grygiel, Sr Officer | ||
| Willem Hassel, Independent Vice Chairman of the Supervisory Board | ||
| Frank Lohner, Independent Member of the Supervisory Board | ||
| Herbert Depp, Independent Member of the Supervisory Board | ||
| Steve Hanke, Independent Chairman of the Supervisory Board | ||
| Jackson Dunckel, Member of the Management Board, Chief Financial Officer | ||
| Michele Fischer, Vice President IR Contact Officer | ||
| Esteban Santos, Ex Operations | ||
| Heinz Schimmelbusch, Chairman of the Management Board, Chief Executive Officer | ||
| Eric Jackson, Member of the Management Board and Presidentident of the AMG Processing Division, COO | ||
| Jonathan Graham, Gen VP | ||
| Mike Zahigian, VP Officer | ||
| David MD, Ex RD | ||
| Arvind Sood, VP Relations |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.38 % | |||
| Current Valuation | 163.09 B | |||
| Shares Outstanding | 533.98 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 79.91 % | |||
| Price To Earning | 17.42 X | |||
| Price To Book | 38.95 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.